Morgan Stanley Oric Pharmaceuticals, Inc. Transaction History

Morgan Stanley

$1.23 Trillion
Q1 2024

A detailed history of Morgan Stanley transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Morgan Stanley holds 300,823 shares of ORIC stock, worth $2.26 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

300,823

Previous 480,331 37.37%

Holding current value

$2.26 Million

Previous $4.42 Million 6.4%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$8.04 - $16.03 $1.44 Million - $2.88 Million	-179,508 Reduced 37.37%	300,823 $4.14 Million
Q4 2023 Feb 13, 2024	BUY	$5.41 - $9.43 $1.93 Million - $3.36 Million	356,140 Added 286.77%	480,331 $4.42 Million
Q3 2023 Nov 15, 2023	SELL	$6.05 - $9.28 $147,559 - $226,339	-24,390 Reduced 16.42%	124,191 $751,000
Q2 2023 Aug 14, 2023	BUY	$4.95 - $8.4 $270,032 - $458,236	54,552 Added 58.02%	148,581 $1.15 Million
Q1 2023 May 15, 2023	BUY	$4.26 - $6.75 $155,294 - $246,064	36,454 Added 63.32%	94,029 $535,000

Q4 2022 Feb 14, 2023	BUY	$2.41 - $5.89 $47,922 - $117,122	19,885 Added 52.76%	57,575 $339,000
Q3 2022 Nov 14, 2022	SELL	$3.28 - $5.24 $136,162 - $217,528	-41,513 Reduced 52.41%	37,690 $121,000
Q2 2022 Oct 27, 2022	BUY	$2.7 - $7.07 $16,216 - $42,462	6,006 Added 8.21%	79,203 $354,000
Q2 2022 Aug 15, 2022	BUY	$2.7 - $7.07 $16,216 - $42,462	6,006 Added 8.21%	79,203 $354,000
Q1 2022 Oct 27, 2022	SELL	$4.54 - $16.1 $27,267 - $96,696	-6,006 Reduced 7.58%	73,197 $391,000
Q1 2022 May 13, 2022	BUY	$4.54 - $16.1 $121,808 - $431,963	26,830 Added 57.86%	73,197 $391,000
Q4 2021 Feb 14, 2022	BUY	$12.01 - $20.3 $329,710 - $557,295	27,453 Added 145.15%	46,367 $681,000
Q3 2021 Nov 15, 2021	BUY	$15.9 - $25.22 $300,732 - $477,011	18,914 New	18,914 $396,000

Others Institutions Holding ORIC

# of Institutions

113

Shares Held

59.3M

Call Options Held

302K

Put Options Held

7.7K

View Full List

About Oric Pharmaceuticals, Inc.

Ticker ORIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,576,700
Market Cap $298M
Description
ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...

More about ORIC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account